Literature DB >> 22293239

Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole.

Ji-Sun Lim1, Kiwon Lee, Jong-Nam Choi, Yong-Kyung Hwang, Mi-Yeon Yun, Hee-Jin Kim, Yong Sun Won, Sung-Jin Kim, Hyockman Kwon, Seong Huh.   

Abstract

We prepared cell membrane-permeable hollow mesoporous silica capsules (HMSCs) by a simple new method. CTAB micellar assembly in cholesterol emulsion gave rise to a novel capsular morphology of the HMSC particles. The HMSCs consisted of mesostructured silica walls with a large surface hole (25-50 nm) and the average particle dimension was 100-300 nm. They exhibited high surface areas of up to 719.3 m(2) g(-1) and a mesoporous range of pores of 2.4-2.7 nm. The surface-functionalized HMSCs could also be prepared by a similar co-condensation method using tetraethoxysilane with various organoalkoxysilane precursors in the presence of cholesterol. These organically modified HMSCs could be further modified on demand. For example, a carboxy-functionalized HMSC could be surface-functionalized by a green fluorescent 5-aminofluorescein (AFL) through an amidation reaction to afford a fluorescent AFL-HMSC. The hollow capsular morphology of the HMSCs with a large surface hole enabled us to develop very efficient intracellular delivery systems for membrane-impermeable ions, molecules, and various functional proteins. Non-covalent sequestration and delivery of proteins as well as covalent linkage of fluorescent molecules on the silica surface are effective for this system. The highly negatively charged green fluorescent probe mag-fluo-4 could be intracellularly delivered into HeLa cells by HMSC without any difficulty. The HMSCs could also effectively transport large functional proteins such as antibodies into HeLa cells. The efficiency of protein delivery by HMSC seems to be 3-22-fold higher than that of mesoporous silica nanospheres (MSNs) based on confocal laser scanning microscopy (CLSM) analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293239     DOI: 10.1088/0957-4484/23/8/085101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  10 in total

Review 1.  Protein delivery into cells using inorganic nanoparticle-protein supramolecular assemblies.

Authors:  Federica Scaletti; Joseph Hardie; Yi-Wei Lee; David C Luther; Moumita Ray; Vincent M Rotello
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

2.  Nanoporous silica nanoparticles as biomaterials: evaluation of different strategies for the functionalization with polysialic acid by step-by-step cytocompatibility testing.

Authors:  Sina Williams; Anne Neumann; Imke Bremer; Yi Su; Gerald Dräger; Cornelia Kasper; Peter Behrens
Journal:  J Mater Sci Mater Med       Date:  2015-02-18       Impact factor: 3.896

Review 3.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 4.  Stimuli-responsive nanomaterials for therapeutic protein delivery.

Authors:  Yue Lu; Wujin Sun; Zhen Gu
Journal:  J Control Release       Date:  2014-08-21       Impact factor: 9.776

5.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

Review 6.  Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers.

Authors:  Yi-Wei Lee; David C Luther; Jessica A Kretzmann; Andrew Burden; Taewon Jeon; Shumei Zhai; Vincent M Rotello
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 7.  Functional Nanoparticles for Enhanced Cancer Therapy.

Authors:  Chenchen Li; Yuqing Li; Guangzhi Li; Song Wu
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

Review 8.  Nanostructured porous Si-based nanoparticles for targeted drug delivery.

Authors:  Mohammad-Ali Shahbazi; Barbara Herranz; Hélder A Santos
Journal:  Biomatter       Date:  2012 Oct-Dec

Review 9.  Nanoparticle Vaccines Against Infectious Diseases.

Authors:  Rashmirekha Pati; Maxim Shevtsov; Avinash Sonawane
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

Review 10.  Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules.

Authors:  Rafael R Castillo; Daniel Lozano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-05-07       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.